Vyne Therapeutics Inc Asset Turnover Ratio (VYNE), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Vyne Therapeutics Inc   (NASDAQ: VYNE)
 

Vyne Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Vyne Therapeutics Inc 's asset turnover ratio has remained unchanged compare to previous quarter at 0.01 in the second quarter (Jun 30 2026)

Within sector 191 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the II Quarter 2026, to 3807, from total ranking in the first quarter 2026 at 4623.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VYNE Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Asset Change -57.03 % -61.27 % -59.07 % -46.95 % -39.02 %
Y / Y Revenue Change -51.98 % 2.38 % 47.11 % -65.15 % 106.12 %
Asset Turnover Ratio (TTM) 0.01 0.01 0.01 0.01 0.01
VYNE's Total Ranking # 3807 # 4623 # # 4011 # 4076
Seq. Asset Change -8.62 % -14.04 % -32.28 % -19.22 % -17.65 %
Seq. Revenue Change 12.79 % -51.69 % 157.97 % -65.84 % 140.48 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 192
Healthcare Sector # 549
Overall Market # 3807

Asset Turnover Ratio Statistics
High Average Low
0.19 0.06 0.01
(Mar 31 2021)   (Sep 30 2024)




VYNE Company Profile • Back to VYNE Efficiency Comparisons • Compare VYNE Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Abcellera Biologics Inc   0.05 $ 66.174  Millions$ 1,331.907  Millions
Monte Rosa Therapeutics Inc   0.05 $ 28.727  Millions$ 584.022  Millions
Insight Molecular Diagnostics Inc   0.05 $ 1.670  Millions$ 34.891  Millions
Dar Bioscience Inc   0.05 $ 1.345  Millions$ 28.355  Millions
Nakamoto Inc   0.05 $ 28.962  Millions$ 616.576  Millions
Agape Atp Corporation  0.05 $ 1.152  Millions$ 24.729  Millions
Aclaris Therapeutics Inc   0.05 $ 8.219  Millions$ 178.602  Millions
Cytokinetics Incorporated  0.04 $ 67.670  Millions$ 1,514.781  Millions
Instil Bio Inc   0.04 $ 8.968  Millions$ 203.358  Millions
Camp4 Therapeutics Corporation  0.04 $ 4.216  Millions$ 100.772  Millions
Recursion Pharmaceuticals Inc   0.04 $ 54.855  Millions$ 1,356.462  Millions
Vistagen Therapeutics Inc   0.04 $ 2.501  Millions$ 62.393  Millions
Kyntra Bio Inc   0.04 $ 4.617  Millions$ 116.829  Millions
X4 Pharmaceuticals Inc  0.04 $ 9.441  Millions$ 244.340  Millions
Blue Water Vaccines Inc  0.03 $ 0.646  Millions$ 18.966  Millions
Pluri Inc   0.03 $ 1.016  Millions$ 30.822  Millions
Tscan Therapeutics Inc   0.03 $ 7.111  Millions$ 216.114  Millions
Northwest Biotherapeutics Inc  0.03 $ 2.173  Millions$ 66.973  Millions
Tao Synergies Inc   0.03 $ 0.772  Millions$ 24.086  Millions
Atrium Therapeutics Inc   0.03 $ 35.974  Millions$ 1,166.283  Millions
Bioage Labs Inc   0.03 $ 10.355  Millions$ 348.641  Millions
Co diagnostics Inc   0.03 $ 0.721  Millions$ 26.893  Millions
Dbv Technologies S a   0.02 $ 5.018  Millions$ 223.351  Millions
Fate Therapeutics Inc   0.02 $ 6.491  Millions$ 301.907  Millions
Medicinova Inc   0.02 $ 0.920  Millions$ 44.080  Millions
Mangoceuticals Inc   0.02 $ 0.315  Millions$ 15.311  Millions
Bioxcel Therapeutics Inc   0.02 $ 0.742  Millions$ 38.133  Millions
Hyperion Defi inc   0.02 $ 1.401  Millions$ 79.440  Millions
Aspire Biopharma Holdings Inc   0.02 $ 0.103  Millions$ 6.093  Millions
Ataibeckley Inc   0.02 $ 4.473  Millions$ 265.553  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.